242 related articles for article (PubMed ID: 18579764)
1. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
[TBL] [Abstract][Full Text] [Related]
2. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma.
Aerts I; Leuraud P; Blais J; Pouliquen AL; Maillard P; Houdayer C; Couturier J; Sastre-Garau X; Grierson D; Doz F; Poupon MF
Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):275-83. PubMed ID: 21112551
[TBL] [Abstract][Full Text] [Related]
4. The killing effect of photodynamic therapy using benzoporphyrin derivative on retinoblastoma cell line in vitro.
Jin C; Wu Z; Li Y; Li Y; Chen H; North J
Yan Ke Xue Bao; 1999 Mar; 15(1):1-6. PubMed ID: 12579652
[TBL] [Abstract][Full Text] [Related]
5. Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.
Kim JW; Jacobsen B; Zolfaghari E; Ferrario A; Chevez-Barrios P; Berry JL; Lee DK; Rico G; Madi I; Rao N; Stachelek K; Wang LC; Gomer C
Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2363-2373. PubMed ID: 28971251
[TBL] [Abstract][Full Text] [Related]
6. Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
Busch M; Papior D; Stephan H; Dünker N
Oncol Rep; 2018 Jan; 39(1):160-172. PubMed ID: 29192327
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines.
Turchiello RF; Oliveira CS; Fernandes AU; Gómez SL; Baptista MS
J Photochem Photobiol B; 2021 Sep; 222():112260. PubMed ID: 34304071
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
10. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
11. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
12. [Towards a new treatment of retinoblastoma?].
Maillard P; Lupu M; Thomas CD; Mispelter J
Ann Pharm Fr; 2010 May; 68(3):195-202. PubMed ID: 20569775
[TBL] [Abstract][Full Text] [Related]
13. Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy.
Aaberg TM; Aaberg TM; Martin DF; Gilman JP; Myles R
Arch Ophthalmol; 2005 Mar; 123(3):328-32. PubMed ID: 15767474
[TBL] [Abstract][Full Text] [Related]
14. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
15. Transient closure of a retinal capillary hemangioma with verteporfin photodynamic therapy.
Bakri SJ; Sears JE; Singh AD
Retina; 2005 Dec; 25(8):1103-4. PubMed ID: 16340546
[No Abstract] [Full Text] [Related]
16. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
Celli JP; Solban N; Liang A; Pereira SP; Hasan T
Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
[TBL] [Abstract][Full Text] [Related]
18. Expression of genes involved in heme biosynthesis in the human retinoblastoma cell lines WERI-Rb-1 and Y79: implications for photodynamic therapy.
Ruiz-Galindo E; Arenas-Huertero F; Ramón-Gallegos E
J Exp Clin Cancer Res; 2007 Jun; 26(2):195-200. PubMed ID: 17725098
[TBL] [Abstract][Full Text] [Related]
19. Efficient photodynamic therapy on human retinoblastoma cell lines.
Walther J; Schastak S; Dukic-Stefanovic S; Wiedemann P; Neuhaus J; Claudepierre T
PLoS One; 2014; 9(1):e87453. PubMed ID: 24498108
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas.
Eskelin S; Tommila P; Palosaari T; Kivelä T
Acta Ophthalmol; 2008 Nov; 86(7):794-9. PubMed ID: 18759802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
